In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis

Journal of Experimental Medicine

Volumn 188, Issue 9, 1998, Pages 1725-1738

  Ufret Vincenty, Rafael L ^a,c   Quigley, Laura ^a   Tresser, Nancy ^b   Pak, Seong Hee ^a   Gado, Ameer ^a   Hausmann, Stefan ^d   Wucherpfennig, Kai W ^d   Brocke, Stefan ^a,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HEBREW UNIVERSITY   (Israel)

Author keywords

Antigenic peptide; Autoimmunity; Cross reactivity; Experimental autoimmune encephalomyelitis; Molecular mimicry

Indexed keywords

VIRUS ANTIGEN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CROSS REACTION; FEMALE; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; AUTOANTIGENS; CELL SURVIVAL; CROSS REACTIONS; CYTOMEGALOVIRUS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GUINEA PIGS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNIZATION, PASSIVE; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0032476612     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.9.1725     Document Type: Article

References (61)

1. Shoenfeld, Y., and R.S. Schwartz. 1984. Immunologic and genetic factors in autoimmune diseases. N. Engl. J. Med. 311: 1019-1029.
2. Ebers, G.C., K. Kukay, D.E. Bulman, A.D. Sadovnick, G. Rice, C. Anderson, H. Armstrong, K. Cousin, R.B. Bell, W. Hader, et al. 1996. A full genome search in multiple sclerosis. Nat. Genet. 13:472-476.
3. Dyment, D.A., A.D. Sadovnick, and G.C. Ebers. 1997. Genetics of multiple sclerosis. Hum. Mol. Genet. 6:1693-1698.
4. Ross, R.T., and M. Cheang. 1995. Geographic similarities between varicella and multiple sclerosis: an hypothesis on the environmental factor of multiple sclerosis. J. Clin. Epidemiol. 48:731-737.
5. Kurtzke, J.F. 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:382-427.
6. Brocke, S., S. Hausmann, L. Steinman, and K.W. Wucherpfennig. 1998. Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system. Semin. Immunol. 10:57-67.
7. Ebers, G.C., and A.D. Sadovnick. 1993. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology. 12:1-5.
8. James, W.H. 1996. Review of the contribution of twin studies in the search for non-genetic causes of multiple sclerosis. Neuroepidemiology. 15:132-141.
9. Leslie, R.D., and M. Hawa. 1994. Twin studies in autoimmune disease. Acta Genet. Med. Gemellol. 43:71-81.
10. Goverman, J., A. Woods, L. Larson, L.P. Weiner, L. Hood, and D.M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:551-560.
11. Oldstone, M.B., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 65:319-331.
12. Ohashi, P.S., S. Oehen, K. Buerki, H. Pircher, C.T. Ohashi, B. Odermatt, B. Malissen, R.M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:305-317.
13. Miller, S.D., C.L. Vanderlugt, W.S. Begolka, W. Pao, R.L. Yauch, K.L. Neville, L.Y. Katz, A. Carrizosa, and B.S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-1136.
14. Lehmann, P.V., T. Forsthuber, A. Miller, and E.E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:155-157.
15. Yu, M., J.M. Johnson, and V.K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777-1788.
16. Brocke, S., A. Gaur, C. Piercy, A. Gautam, K. Gijbels, C.G. Fathman, and L. Steinman. 1993. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature. 365:642-644.
17. Fujinami, R.S., and M.B. Oldstone. 1985. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 230: 1043-1045.
18. Davies, J.M. 1997. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol. Cell Biol. 75:113-126.
19. Wucherpfennig, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705.
20. Garza, K.M., and K.S. Tung. 1995. Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction. J. Immunol. 155:5444-5448.
21. Huber, S.A., and M.W. Cunningham. 1996. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. J. Immunol. 156:3528-3534.
22. Zhao, Z., F. Granucci, L. Yeh, P.A. Schaffer, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 279:1344-1347.
23. Ausubel, L.J., C.K. Kwan, A. Sette, V. Kuchroo, and D.A. Hafler. 1996. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc. Natl. Acad. Sci. USA. 93:15317-15322.
24. Vergelli, M., B. Hemmer, M. Kalbus, A.B. Vogt, N. Ling, P. Conlon, J.E. Coligan, H. McFarland, and R. Martin. 1997. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. J. Immunol. 158:3746-3752.
25. Hemmer, B., B.T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K.H. Wiesmuller. 1997. Identification of high potency microbial and self-ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185: 1651-1659.
26. Warren, K.G., I. Catz, and L. Steinman. 1995. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. Proc. Natl. Acad. Sci. USA. 92:11061-11065.
27. Wucherpfennig, K.W., I. Catz, S. Hausmann, J.L. Strominger, L. Steinman, and K.G. Warren. 1997. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J. Clin. Invest. 100:1114-1122.
28. Zamvil, S.S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579-621.
29. Dal Canto, M.C., R.W. Melvold, B.S. Kim, and S.D. Miller. 1995. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc. Res. Tech. 32:215-229.
30. Wolf, S.D., B.N. Dittel, F. Hardardottir, and C.A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:2271-2278.
31. Hafler, D.A., and H.L. Weiner. 1995. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144: 75-107.
32. Fritz, R.B., C.H. Chou, and D.E. McFarlin. 1983. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130:1024-1026.
33. Mokhtarian, F., D.E. McFarlin, and C.S. Raine. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature. 309:356-358.
34. Brocke, S., L. Quigley, H.F. McFarland, and L. Steinman. 1996. Isolation and characterization of autoreactive T cells in experimental autoimmune encephalomyelitis of the mouse. Methods. 9:458-462.
35. Gautam, A.M., C.B. Lock, D.E. Smilek, C.I. Pearson, L. Steinman, and H.O. McDevitt. 1994. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity. Proc. Natl. Acad. Sci. USA. 91:767-771.
36. Sakai, K., S.S. Zamvil, D.J. Mitchell, M. Lim, J.B. Rothbard, and L. Steinman. 1988. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19:21-32.
37. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
38. Pette, M., K. Fujita, B. Kitze, J.N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology. 40:1770-1776.
39. Martin R., D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker, E.O. Long, D.E. McFarlin, and H.F. McFarland. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540-548.
40. Deibler, G.E., R.E. Martenson, and M.W. Kies. 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:139-165.
41. Segal, B.M., and E.M. Shevach. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:771-775.
42. Speiser, D.E., D. Kyburz, U. Stubi, H. Hengartner, and R.M. Zinkernagel. 1992. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J. Immunol. 149:972-980.
43. Aichele, P., M.F. Bachmann, H. Hengartner, and R.M. Zinkernagel. 1996. Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol. Rev. 152:21-45.
44. Brocke, S., T. Veromaa, I.L. Weissman, K. Gijbels, and L. Steinman. 1994. Infection and multiple sclerosis: a possible role for superantigens? Trends Microbiol. 2:250-254.
45. Fallis, R.J., C.S. Raine, and D.E. McFarlin. 1989. Chronic relapsing experimental allergic encephalomyelitis in SJL mice following the adoptive transfer of an epitope-specific T cell line. J. Neuroimmunol. 22:93-105.
46. Wekerle, H., C. Linington, H. Lassmann, and R. Meyermann. 1986. Cellular immune reactivity within the CNS. Trends Neurosci. 6:271-277.
47. Hickey, W.F., B.L. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:254-260.
48. Panitch, H.S. 1980. Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: comparison of in vitro activation by concanavalin A and myelin basic protein. Cell. Immunol. 56:163-171.
49. Ben-Nun, A., H. Wekerle, and I.R. Cohen. 1981. The rapid isolation of clonablc antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195-199.
50. Hamad, A.R., P. Marrack, and J.W. Kappler. 1997. Transcytosis of staphylococcal superantigen toxins. J. Exp. Med. 185: 1447-1454.
51. Davis, B.D., R. Dulbecco, H.N. Eisen, H.S. Ginsberg, and W.B. Wood. 1970. Microbiology. 6th ed. Hoeber Medical Division, New York.
52. Gray, D., and P. Matzinger. 1991. T cell memory is shortlived in the absence of antigen. J. Exp. Med. 174:969-974.
53. Beverley, P.C. 1990. Is T-cell memory maintained by cross-reactive stimulation? Immunol. Today. 11:203-205.
54. Matzinger, P. 1994. Immunology. Memories are made of this? Nature. 369:605-606.
55. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
56. Miller, S.D., C.L. Vanderlugt, D.J. Lenschow, J.G. Pope, N.J. Karandikar, C.M. Dal, and J.A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:739-745.
57. Vanderlugt, C.L., N.J. Karandikar, D.J. Lenschow, C.M. Dal, J.A. Bluestone, and S.D. Miller. 1997. Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. J. Neuroimmunol. 79:113-118.
58. Perrin, P.J., J.H. Maldonado, T.A. Davis, C.H. June, and M.K. Racke. 1996. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1333-1336.
59. Perrin, P.J., D. Scott, C.H. June, and M.K. Racke. 1995. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis. Immunol.Res. 14:189-199.
60. Grewal, I.S., H.G. Foellmer, K.D. Grewal, J. Xu, F. Hardardottir, J.L. Baron, C.A. Janeway, Jr., and R.A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1864-1867.
61. McRae, B.L., K.M. Nikcevich, W.J. Karpus, S.D. Hurst, and S.D. Miller. 1995. Differential recognition of peptide analogs by naive versus activated PLP 139-151-specific CD4+ T cells. J. Neuroimmunol. 60:17-28.